
Marathon Partners' Mario Cibelli updates the Remitly Thesis $RELY
About this episode
In this episode of Yet Another Value Podcast, host Andrew Walker welcomes back Mario Cibelli of Marathon Partners for his fifth appearance. This time, they revisit Remitly (RELY), a name Mario originally pitched a year ago on podcast #266. The stock has seen ups and downs since, prompting a fresh look at its fundamentals, growth trajectory, and competitive standing—especially against players like Wise. The duo explores key risks including stablecoin disruption, regulatory dynamics, fraud prevention, and recent product launches like Remitly One and Remitly Business. Mario also explains why he believes the market misunderstands Remitly’s valuation and long-term potential.
______________________________________________________________________
[00:00:00] Intro: Mario returns, Remitly focus
[00:02:15] Fifth time guest, same topic
[00:03:18] Quick disclaimer, start discussion
[00:04:51] Remitly vs. Wise comparison
[00:09:26] Market concerns despite guidance
[00:14:16] Stablecoin threat deeply discussed
[00:20:15] Conversion costs with stablecoins
[00:24:55] Fraud handling, hidden barrier
[00:28:50] AML/KYC as entry barrier
[00:32:17] Remitly potentially stablecoin beneficiary
[00:35:15] Stablecoins: trend or transformation?
[00:38:19] If Remitly fails, what happened?
[00:42:44] Growth, valuation, market misunderstanding
[00:44:16] New products: Remitly One, Business
[00:48:44] Personal plan boosts repeat use
[00:50:26] Closing thoughts, insider selling discussed
[00:57:35] Narrative shift, comp valuation contrast
[58:14:00] Sign-off and exclusive shirt chat
Links:
Yet Another Value Blog - https://www.yetanothervalueblog.com
See our legal disclaimer here: https://www.yetanothervalueblog.com/p/legal-and-disclaimer
Get every episode summarized
Each time Yet Another Value Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Yet Another Value Podcast

$STVN: are oral GLP-1s really a death blow? | Aurelian Research's Leo Trudel
Yet Another Value Podcast

Can Sprout Social Survive the SaaSpocalypse with Pernas Research's Deiya Pernas...
Yet Another Value Podcast

Chadd Garcia drills into LandBridge's value
Yet Another Value Podcast

Investing in the SaaSpocalypse with Heller House's Marcelo Lima
Yet Another Value Podcast